118 related articles for article (PubMed ID: 27939696)
1. STC2 as a novel mediator for Mus81-dependent proliferation and survival in hepatocellular carcinoma.
Wu F; Li TY; Su SC; Yu JS; Zhang HL; Tan GQ; Liu JW; Wang BL
Cancer Lett; 2017 Mar; 388():177-186. PubMed ID: 27939696
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma.
Wang Y; Wu J; Xu J; Lin S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962272
[TBL] [Abstract][Full Text] [Related]
3. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.
Wang H; Wu K; Sun Y; Li Y; Wu M; Qiao Q; Wei Y; Han ZG; Cai B
BMB Rep; 2012 Nov; 45(11):629-34. PubMed ID: 23187001
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of methyl methansulfonate and ultraviolet-sensitive gene clone 81 (Mus81) is correlated with a poor prognosis in patients with hepatocellular carcinoma.
Wu F; Liu SY; Tao YM; Ou DP; Fang F; Yang LY
Cancer; 2008 May; 112(9):2002-10. PubMed ID: 18327812
[TBL] [Abstract][Full Text] [Related]
5. Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S-phase arrest and promoting apoptosis through CHK1 pathway.
Wu F; Chen WJ; Yan L; Tan GQ; Li WT; Zhu XJ; Ge XC; Liu JW; Wang BL
Cancer Med; 2016 Feb; 5(2):370-85. PubMed ID: 26714930
[TBL] [Abstract][Full Text] [Related]
6. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma.
Wang W; Jia WD; Hu B; Pan YY
Oncotarget; 2017 Apr; 8(16):26434-26447. PubMed ID: 28460436
[TBL] [Abstract][Full Text] [Related]
7. RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway.
Wang S; Huang X; Li Y; Lao H; Zhang Y; Dong H; Xu W; Li JL; Li M
Hepatology; 2011 Jun; 53(6):1932-42. PubMed ID: 21391225
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.
Lv X; Zhao F; Huo X; Tang W; Hu B; Gong X; Yang J; Shen Q; Qin W
Med Oncol; 2016 Jul; 33(7):70. PubMed ID: 27262566
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
[TBL] [Abstract][Full Text] [Related]
10. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
12. STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells.
Bu Q; Deng Y; Wang Q; Deng R; Hu S; Pei Z; Zhang Y
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127575. PubMed ID: 37866563
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.
Zhao F; Gong X; Liu A; Lv X; Hu B; Zhang H
Biochem Biophys Res Commun; 2018 Jan; 495(1):1136-1143. PubMed ID: 29175326
[TBL] [Abstract][Full Text] [Related]
14. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
15. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-485-5p suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting stanniocalcin 2.
Guo GX; Li QY; Ma WL; Shi ZH; Ren XQ
Int J Clin Exp Pathol; 2015; 8(10):12292-9. PubMed ID: 26722415
[TBL] [Abstract][Full Text] [Related]
17. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
18. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
[TBL] [Abstract][Full Text] [Related]
19. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
[TBL] [Abstract][Full Text] [Related]
20. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]